Background: The achievement of high rates of sustained virological response (SVR) with direct-acting antivirals (DAAs) in hepatitis C virus (HCV) infected patients will reduce decompensating terminal events. Aims: To investigate whether hepatocellular carcinoma (HCC) occurrence could change due to the DAA-induced increase in life-expectancy. Methods: A Markov model was built on clinical data of 494 cirrhotic patients and available literature to estimate probabilities of “death before HCC” and of “HCC occurrence” without and with DAA. Results: In comparison to untreated patients, DAA therapy reduced the 20-year mortality before HCC by 21.9% in patients without varices and by 21.5% in those with varices, considering an SVR of 95% and no direct effect on hepatocarcinogenesis. Tumour occurrence increased by 5%–8.2% and the proportion of HCCs diagnosed in compensated stages increased to >98%. If we consider DAA as having “anti-tumoral” effects, the benefit becomes greater, achieving a 20-year survival of 81.5% in patients without varices, and 52.2% in patients with varices. Instead, if we consider DAA as having a “pro-tumoral” effect, then, the increased incidence of HCC nullifies the survival benefits. Conclusion: DAAs drastically reduce the mortality caused by the liver function worsening, increasing the proportion of HCCs diagnosed in compensated stages. Knowledge of the DAA effect on hepatocarcinogenesis remains pivotal.

Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients / Cucchetti, Alessandro; D’Amico, Gennaro; Trevisani, Franco; Morelli, Maria Cristina; Vitale, Alessandro; Pinna, Antonio Daniele; Cescon, Matteo; Cillo, Umberto; Burra, Patrizia; Russo, Francesco P.; Mescoli, Claudia; Rendina, Maria; Lupo, Luigi G.; Losito, Francesco; Fucilli, Fabio; Brancaccio, Giusep-Pina; Persico, Marcello; Viganò, Luca; Iavarone, Massimo; D’Ambrosio, Roberta; Sangiovanni, Angelo; Renzulli, Matteo; Galati, Giovanni; Ponziani, Francesca Romana; Pompili, Maurizio; Miele, Luca; Grieco, Antonio; Rapaccini, Gianlodovico; Gasbarrini, Antonio; Sandri, Giovanni Battisa Levi; Lai, Quirino; Melandro, Fabio; Rossi, Massimo; Lenci, Ilaria; Manzia, Tommaso Maria; Tortora, Raffaella; Di Costanzo, Giovan Giuseppe; Sacco, Rodolfo; Simonetti, Natalia; Morisco, Filomena; Guarino, Maria; Cabibbo, Giuseppe; Bhoori, Carlo Sposito Sherrie; Di Sandro, Stefano; Foschi, Francesco Giuseppe; Gardini, Andrea Casadei; Nicolini, Daniele; Mazzocato, Susanna; Alba, Kostandini; Violi, Paola; Baccarani, Umberto; Pravisani, Riccardo. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - 50:2(2018), pp. 156-162. [10.1016/j.dld.2017.10.004]

Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients

Pinna, Antonio Daniele;Rossi, Massimo;Guarino, Maria;Di Sandro, Stefano;Gardini, Andrea Casadei;
2018

Abstract

Background: The achievement of high rates of sustained virological response (SVR) with direct-acting antivirals (DAAs) in hepatitis C virus (HCV) infected patients will reduce decompensating terminal events. Aims: To investigate whether hepatocellular carcinoma (HCC) occurrence could change due to the DAA-induced increase in life-expectancy. Methods: A Markov model was built on clinical data of 494 cirrhotic patients and available literature to estimate probabilities of “death before HCC” and of “HCC occurrence” without and with DAA. Results: In comparison to untreated patients, DAA therapy reduced the 20-year mortality before HCC by 21.9% in patients without varices and by 21.5% in those with varices, considering an SVR of 95% and no direct effect on hepatocarcinogenesis. Tumour occurrence increased by 5%–8.2% and the proportion of HCCs diagnosed in compensated stages increased to >98%. If we consider DAA as having “anti-tumoral” effects, the benefit becomes greater, achieving a 20-year survival of 81.5% in patients without varices, and 52.2% in patients with varices. Instead, if we consider DAA as having a “pro-tumoral” effect, then, the increased incidence of HCC nullifies the survival benefits. Conclusion: DAAs drastically reduce the mortality caused by the liver function worsening, increasing the proportion of HCCs diagnosed in compensated stages. Knowledge of the DAA effect on hepatocarcinogenesis remains pivotal.
18-ott-2017
50
2
156
162
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients / Cucchetti, Alessandro; D’Amico, Gennaro; Trevisani, Franco; Morelli, Maria Cristina; Vitale, Alessandro; Pinna, Antonio Daniele; Cescon, Matteo; Cillo, Umberto; Burra, Patrizia; Russo, Francesco P.; Mescoli, Claudia; Rendina, Maria; Lupo, Luigi G.; Losito, Francesco; Fucilli, Fabio; Brancaccio, Giusep-Pina; Persico, Marcello; Viganò, Luca; Iavarone, Massimo; D’Ambrosio, Roberta; Sangiovanni, Angelo; Renzulli, Matteo; Galati, Giovanni; Ponziani, Francesca Romana; Pompili, Maurizio; Miele, Luca; Grieco, Antonio; Rapaccini, Gianlodovico; Gasbarrini, Antonio; Sandri, Giovanni Battisa Levi; Lai, Quirino; Melandro, Fabio; Rossi, Massimo; Lenci, Ilaria; Manzia, Tommaso Maria; Tortora, Raffaella; Di Costanzo, Giovan Giuseppe; Sacco, Rodolfo; Simonetti, Natalia; Morisco, Filomena; Guarino, Maria; Cabibbo, Giuseppe; Bhoori, Carlo Sposito Sherrie; Di Sandro, Stefano; Foschi, Francesco Giuseppe; Gardini, Andrea Casadei; Nicolini, Daniele; Mazzocato, Susanna; Alba, Kostandini; Violi, Paola; Baccarani, Umberto; Pravisani, Riccardo. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - 50:2(2018), pp. 156-162. [10.1016/j.dld.2017.10.004]
Cucchetti, Alessandro; D’Amico, Gennaro; Trevisani, Franco; Morelli, Maria Cristina; Vitale, Alessandro; Pinna, Antonio Daniele; Cescon, Matteo; Cillo, Umberto; Burra, Patrizia; Russo, Francesco P.; Mescoli, Claudia; Rendina, Maria; Lupo, Luigi G.; Losito, Francesco; Fucilli, Fabio; Brancaccio, Giusep-Pina; Persico, Marcello; Viganò, Luca; Iavarone, Massimo; D’Ambrosio, Roberta; Sangiovanni, Angelo; Renzulli, Matteo; Galati, Giovanni; Ponziani, Francesca Romana; Pompili, Maurizio; Miele, Luca; Grieco, Antonio; Rapaccini, Gianlodovico; Gasbarrini, Antonio; Sandri, Giovanni Battisa Levi; Lai, Quirino; Melandro, Fabio; Rossi, Massimo; Lenci, Ilaria; Manzia, Tommaso Maria; Tortora, Raffaella; Di Costanzo, Giovan Giuseppe; Sacco, Rodolfo; Simonetti, Natalia; Morisco, Filomena; Guarino, Maria; Cabibbo, Giuseppe; Bhoori, Carlo Sposito Sherrie; Di Sandro, Stefano; Foschi, Francesco Giuseppe; Gardini, Andrea Casadei; Nicolini, Daniele; Mazzocato, Susanna; Alba, Kostandini; Violi, Paola; Baccarani, Umberto; Pravisani, Riccardo
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1590865817312550-main.pdf

non disponibili

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 682.49 kB
Formato Adobe PDF
682.49 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1177640
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 7
social impact